UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 同種造血細胞移植の適応判定 determining eligibility for allogeneic hematopoietic cell transplantation
2. 候補となり得る腎移植レシピエントの評価 evaluation of the potential renal transplant recipient
3. 自家造血幹細胞移植の適格性判定 determining eligibility for autologous hematopoietic cell transplantation
4. 小児における急性肝不全：マネージメント acute liver failure in children management
5. 移植後リンパ球増殖性疾患の疫学、臨床症状、および診断 epidemiology clinical manifestations and diagnosis of post transplant lymphoproliferative disorders

English Journal

Stewart GC, Mayer JE Jr.SourceDivision of Cardiovascular Medicine, Center for Advanced Heart Disease, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. Electronic address: gcstewart@partners.org.
Heart failure clinics.Heart Fail Clin.2014 Jan;10(1):207-18. doi: 10.1016/j.hfc.2013.09.007.
Heart transplantation has become an increasingly common and effective therapy for adults with end-stage congenital heart disease (CHD) because of advances in patient selection and surgical technique. Indications for transplantation in CHD are similar to other forms of heart failure. Pretransplant as
PMID 24275305

Eculizumab long-term therapy for pediatric renal transplant in aHUS with CFH/CFHR1 hybrid gene.

Román-Ortiz E, Mendizabal Oteiza S, Pinto S, López-Trascasa M, Sánchez-Corral P, Rodríguez de Cordoba S.SourcePediatric Nephrology Unit, Hospital La Fe, Bulevar sur s/n, 46026, Valencia, Spain, eroman@comv.es.
Pediatric nephrology (Berlin, Germany).Pediatr Nephrol.2014 Jan;29(1):149-53. doi: 10.1007/s00467-013-2591-8. Epub 2013 Aug 24.
BACKGROUND: Atypical hemolytic uremic syndrome (aHUS) is a form of thrombotic microangiopathy (TMA) caused by dysregulation of the complement system. Outcomes of kidney transplantation are poor owing to aHUS recurrence and loss of graft. Patients carrying CFH mutations or CFH/CFHR1 hybrid genes pres
PMID 23982707

Cerebral Vascular Abnormalities in Pediatric Patients With Sickle Cell Disease After Hematopoietic Cell Transplant.

Bodas P, Rotz S.Source*Department of Pediatric Hematology and Oncology, Akron Children's Hospital, Akron, OH †Department of Pediatrics, Case Western Reserve University, and Rainbow Babies and Children's Hospital, Cleveland, OH.
Journal of pediatric hematology/oncology.J Pediatr Hematol Oncol.2013 Dec 10. [Epub ahead of print]
OVERVIEW:: Stroke is a common sequela of sickle cell disease (SCD). Patients with SCD who undergo hematopoietic stem cell transplantation (HSCT) with successful engraftment will not experience sickling. This ameliorates one aspect of stroke risk; however, the significance of preexisting cerebrovascu
PMID 24327127